EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

A General Framework for the Evaluation of Clinical Trial Quality

Vance W Berger, Sunny Y Alperson

Reviews on Recent Clinical Trials · 01.05.2009 · 4 (2) · 79-88

DOI: 10.2174/157488709788186021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews on Recent Clinical Trials, erschienen am 01.05.2009. Verfasst von Vance W Berger und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes of Health/National Cancer Institute, 6130 Executive Boulevard, MSC-7354, Bethesda, MD 20892-7354 USA. bergerv@mail.nih.gov. Die Arbeit wurde bisher 212-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flawed evaluation of clinical trial quality allows flawed trials to thrive (get funded, obtain IRB approval, get published, serve as the basis of regulatory approval, and set policy). A reasonable evaluation of clinical trial quality must recognize that any one of a large number of potential biases could by itself completely invalidate the trial results. In addition, clever new ways to distort trial results toward a favored outcome may be devised at any time. Finally, the vested financial and other interests of those conducting the experiments and publishing the reports must cast suspicion on any inadequately reported aspect of clinical trial quality. Putting these ideas together, we see that an adequate evaluation of clinical quality would need to enumerate all known biases, update this list periodically, score the trial with regard to each potential bias on a scale of 0% to 100%, offer partial credit for only that which can be substantiated, and then multiply (not add) the component scores to obtain an overall score between 0% and 100%. We will demonstrate that current evaluations fall well short of these ideals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicEvaluation Studies as Topic

Autor:innen und Institutionen

  • National Institutes of Health/National Cancer Institute, 6130 Executive Boulevard, MSC-7354, Bethesda, MD 20892-7354 USA. bergerv@mail.nih.gov

Förderung

  • Intramural NIH HHS

Zitieren

APA

Berger, V. W., & Alperson, S. Y. (2009). A General Framework for the Evaluation of Clinical Trial Quality. Reviews on Recent Clinical Trials, 4(2), 79-88. https://doi.org/10.2174/157488709788186021

Vancouver

Berger VW, Alperson SY. A General Framework for the Evaluation of Clinical Trial Quality. Reviews on Recent Clinical Trials. 2009;4(2):79-88. doi:10.2174/157488709788186021

BibTeX
@article{Berger2009,
  author = {Berger, Vance W and Alperson, Sunny Y},
  title = {A General Framework for the Evaluation of Clinical Trial Quality},
  journal = {Reviews on Recent Clinical Trials},
  year = {2009},
  volume = {4},
  number = {2},
  pages = {79--88},
  doi = {10.2174/157488709788186021}
}
Kostenlos starten →